People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Crosslink Therapeutics Inc. | — | Pharmaceuticals | Series A | $4.3M | $15.3M | 2025 |
Andrew D. King at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew D. King on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ronald D. Seidel, III | 1 | 1 |
| Cameron D. Gallagher | 1 | 1 |
| Lou D. Tartaglia | 1 | 1 |
| Rodolfo D. Chaparro | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.